- Home
- INSM
INSM
Insmed Incorporated
as 01-22-2025 4:00pm EST
| Founded: | 1988 | Country: | United States |
| Employees: | N/A | City: | BRIDGEWATER |
| Market Cap: | N/A | IPO Year: | 2000 |
| Target Price: | $84.29 | AVG Volume (30 days): | 1.9M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 16 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.56 | EPS Growth: | N/A |
| 52 Week Low/High: | $21.92 - $80.53 | Next Earning Date: | 02-20-2025 |
| Revenue: | $342,958,000 | Revenue Growth: | 22.13% |
| Revenue Growth (this year): | 19.22% | Revenue Growth (next year): | 41.46% |
Stock Insider Trading Activity of Insmed Incorporated (INSM)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Lewis William | INSM | Chair and CEO | Jan 15 '25 | Sell | $70.25 | 38,635 | $2,711,456.32 | 379,534 | |
| Flammer Martina M.D. | INSM | Chief Medical Officer | Jan 14 '25 | Sell | $68.72 | 1,384 | $95,108.48 | 100,165 | |
| Schaeffer Orlov S Nicole | INSM | Chief People Strategy Officer | Jan 14 '25 | Sell | $68.72 | 872 | $59,923.84 | 97,083 | |
| Adsett Roger | INSM | Chief Operating Officer | Jan 14 '25 | Sell | $68.72 | 1,457 | $100,125.04 | 146,082 | |
| Lewis William | INSM | Chair and CEO | Jan 7 '25 | Sell | $65.11 | 15,195 | $995,012.48 | 379,534 | |
| Flammer Martina M.D. | INSM | Chief Medical Officer | Jan 7 '25 | Sell | $64.85 | 11,218 | $725,820.81 | 100,165 | |
| Schaeffer Orlov S Nicole | INSM | Chief People Strategy Officer | Jan 7 '25 | Sell | $64.80 | 7,862 | $508,972.63 | 97,083 | |
| Bonstein Sara | INSM | Chief Financial Officer | Jan 7 '25 | Sell | $65.16 | 6,000 | $392,601.72 | 113,272 | |
| Adsett Roger | INSM | Chief Operating Officer | Jan 7 '25 | Sell | $64.88 | 9,228 | $597,758.76 | 146,082 | |
| Wise John Drayton | INSM | Chief Commercial Officer | Jan 7 '25 | Sell | $65.87 | 13,587 | $896,074.08 | 122,492 |
Latest Insmed Incorporated News
INSM Breaking Stock News: Dive into INSM Ticker-Specific Updates for Smart Investing
Simply Wall St.
2 days ago
The five-year returns have been solid for Insmed (NASDAQ:INSM) shareholders despite underlying losses increasing
Insider Monkey
5 days ago
Is Insmed Incorporated (INSM) One of the Best Russell 2000 Stocks to Invest in According to Analysts?
MT Newswires
7 days ago
Insmed Insider Sold Shares Worth $2,711,456, According to a Recent SEC Filing
Pharmaceutical Technology
8 days ago
Insmed’s gene therapy poised to challenge DMD landscape after IND clearance
Insider Monkey
10 days ago
Why INSM Stock Is Advancing Today
Argus Research
10 days ago
Daily – Vickers Top Buyers & Sellers for 01/13/2025
MT Newswires
13 days ago
Insmed Says Full-year Revenue Expected to Rise 19%
PR Newswire
13 days ago
Insmed Provides Business Update at 43rd Annual J.P. Morgan Healthcare Conference
Compare INSM vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "INSM Insmed Incorporated - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.